No phaseCompleted
Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care
Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care- a One-year Pragmatic Randomized Controlled Trial
- Sponsor
- Chinese University of Hong Kong (Academic or other)
- Enrolment
- 228 enrolled
- Conditions
- Knee Osteoarthritis
- Interventions
- Risk assessment and Management Programme - Knee Osteoarthritis
- Ages
- adults, older adults
- Registry
- NCT06283147
From the registry
The goal of this clinical trial is to determine the clinical effectiveness of a Chronic Care Model (CCM) named Risk Assessment and Management Program on Knee OA (RAMP-Knee OA) in adults with knee Osteoarthritis (Knee OA) at 52 weeks. Participants will be screened for eligibility to participate. After confirming eligibility, participants will complete the baseline assessment and be randomized into one of the following groups (n=114 for each group): 1. RAMP Knee-OA group 2. Usual care group Outcomes will be measured at baseline, week 16, week 32, and week 52.
Primary outcomes
- Knee pain